Background: Medical cannabis (MC) is used by Canadian Veterans to manage a wide range of health issues. However, there is little information comparing the reasons for MC use and its perceived effectiveness between Veterans and non-Veterans.
Objects: We compared MC use among a convenience sample of Canadian Veterans and with non-Veteran controls, including demographics, reasons and patterns of use, and perceived effectiveness.
Methods: Between November and December 2021, Canadian Veterans using cannabis were invited to participate in a survey using a national press release, social media, and announcements on online platform dedicated to promoting health among Canadian Veterans and non-Veterans during the pandemic (www.MissionVav.com). The survey was also mentioned in a monthly newsletter from Veteran Affairs Canada. Self-reported effectiveness was evaluated using a 0 to 10 visual analogue scale (0 being not all effective, 10 being the most effective).
Results: The survey was completed by 157 people, including 108 (69%) males and 49 (31%) females. The mean age was 57 years (range 19 to 84). Among responders, 90 (63%) identified as Veterans. The most common reasons for MC use among Veterans included: insomnia (80%), anxiety (73%), and depression (52%). Veterans reported medical conditions such as chronic pain (88%) and arthritis (51%). Compared with non-Veterans, Veterans were significantly more likely to be male (83% vs. 49%), have a higher BMI (35.2 vs. 30.9), to report problems with sleep, anxiety, depression, and PTSD, and to use cannabis in edible form (51% vs. 22%). Self-reported mean effectiveness scores for MC were highest for PTSD (8.4), insomnia (8.2), anxiety (8.1), depression (8.0), and chronic pain (7.6).
Conclusions: We found important differences in user characteristics and cannabis use patterns between Canadian Veterans and non-Veterans. Further controlled studies are required to validate these findings, but these data suggest that orally administered cannabis products may be worth further study.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619467 | PMC |
http://dx.doi.org/10.1089/imr.2023.0022 | DOI Listing |
J Am Board Fam Med
January 2025
Affiliations: Editor in Chief, Family Medicine; Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin, Health Sciences Learning Center750 Highland Avenue Madison, WI (SS); Deputy Editor, Journal of the American Board of Family Medicine; Department of Family and Community Medicine, Medical College of Georgia,Augusta University, Augusta, GA (DAS); Editor in Chief, American Family Physician and FP Essentials; Department of Family Medicine, Georgetown University School of Medicine, Washington DC (SMS); Editor in Chief, Annals of Family Medicine; Alpert Medical School, Brown University, Richmond St, Providence, RI (CRR); Editor in Chief, Evidence-Based Practice; University of Washington/Valley Medical Center FMR, Renton, WA (JN); Scientific Editor, Canadian Family Physician; Department of Family and Community Medicine, University of Toronto, Ontario (NP); Editor in Chief, Journal of the American Board of Family Medicine; Veterans Health Administration (MAB); Deputy Editor, Family Medicine; Family and Preventive Medicine, Spencer Fox Eccles School of Medicine, University of Utah Health, Salt Lake City, UT (JR); Editor in Chief, PRiMER; Departments of Public Health & Preventive Medicine and Family Medicine, SUNY Upstate Medical University, Weiskotten Hall, NY (CPM); Editor in Chief, Family Medicine and Community Health; Department of Family Medicine, University of Virginia, VA (LL); Medical Editor, FPM; Pioneer Physicians Network (JDD).
Lancet Diabetes Endocrinol
January 2025
Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Catholic University of the Sacred Heart, Rome, Italy; University Polyclinic Foundation Agostino Gemelli IRCCS, Rome, Italy.
Harm Reduct J
January 2025
Department of Psychology, Memorial University of Newfoundland, St. John's, NL, Canada.
Background: Canadian Veterans experiencing chronic pain report concerns about accessing accurate information on the risks associated with medical cannabis (MC) use. The Lower Risk Cannabis Use Guidelines (LRCUG) were developed to equip individuals who use cannabis recreationally with safer-use strategies. Many of the harm reduction recommendations for recreational cannabis use are relevant and important considerations for MC use.
View Article and Find Full Text PDFFam Med Community Health
January 2025
FPM, New York, New York, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!